Genetic instabilities in human cancers
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic defects such as DNA mismatch repair deficiencies (dMMR) and microsatellite instability (MSI) predispose tumor cells to the accumulation of somatic mutations and are associated with increased TMB (Lengauer et al., 1998) and increased susceptibility to ICB (Le et al., 2017).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Lengauer et al., 1998
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Cited by
Items 401–500 of 1,009
Macleod, K. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00041-6 · Cited by 173
Aneuploid colon cancer cells have a robust spindle checkpoint
Tighe, A., Johnson, V. L., Albertella, M., & Taylor, S. S. (2001) · EMBO reports · doi:10.1093/embo-reports/kve127 · Cited by 174
“…CIN and MIN, or neither, these two phenotypes are generally mutually exclusive (Lengauer et al., 1997; Georgiades et al., 1999; AbdelRahman et al., 2001), suggesting that one or the other is required for the evolution of the majority of colon cancers (Lengauer et al., 1998; Cahill et al., 1999b).”
BackgroundThe Chromosomal Basis of Cancer
Duesberg, P., Li, R., Fabarius, A., & Hehlmann, R. (2005) · Analytical Cellular Pathology · doi:10.1155/2005/951598 · Cited by 175
“This inherent karyotypic–phenotypic variability of cancer cells is the reason, why most cancers are “enormously” heterogeneous populations of non-clonal and partially clonal cells, which differ from each other in “bewildering” [155] phenotypic and chromosomal variations [124,248] – even though most cancers are derived…”
BackgroundInfluentialEvolution of intratumoral genetic heterogeneity during colorectal cancer progression
Losi, L., Baisse, B., Bouzourene, H., & Benhattar, J. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi044 · Cited by 174
Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance
Fitzgerald, D. M., Hastings, P. J., & Rosenberg, S. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121919 · Cited by 171
“Genomic instability fuels many cancers (reviewed in Lengauer et al. 1998, Lee et al. 2016) by increasing the probability of mutations, which drive every stage of cancer progression.”
BackgroundColorectal Cancers: An Update on Their Molecular Pathology
Inamura, K. (2018) · Cancers · doi:10.3390/cancers10010026 · Cited by 174
Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis.
Rabinovitch, P. S., Dziadon, S. M., Brentnall, T. A., Emond, M. J., Crispin, D. A., Haggitt, R. C., & Bronner, M. P. (1999) · PubMed · Cited by 174
Carcinogen-specific induction of genetic instability
Bardelli, A., Cahill, D. P., Lederer, G., Speicher, M. R., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082898 · Cited by 175
Mashevich, M., Folkman, D., Kesar, A., Barbul, A., Korenstein, R., Jerby, E., & Avivi, L. (2003) · Bioelectromagnetics · doi:10.1002/bem.10086 · Cited by 174
“’’ Evidence for a mutator phenotype is the frequent occurrence of aneuploidy displayed in most of human cancers [Lengauer et al., 1998; Pihan and Doxsey, 1999; Duesberg and Rasnick, 2000; Li et al., 2000; Bialy, 2001].”
BackgroundCandidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
Chadwick, R. B., Jiang, G.-L., Bennington, G. A., Yuan, B., Johnson, C. K., Stevens, M. W., Niemann, T. H., Peltomaki, P., Huang, S., & de la Chapelle, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040579497 · Cited by 174
Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability
Shin, H.-J., Baek, K.-H., Jeon, A.-H., Park, M.-T., Lee, S.-J., Kang, C.-M., Lee, H.-S., Yoo, S.-H., Chung, D.-H., Sung, Y.-C., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00302-7 · Cited by 172
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
Endo, Y., Marusawa, H., Kinoshita, K., Morisawa, T., Sakurai, T., Okazaki, I.-M., Watashi, K., Shimotohno, K., Honjo, T., & Chiba, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210344 · Cited by 172
“On the other hand, human cancer develops by a multistep process occurring through the accumulation of gene alterations that govern cell proliferation, regeneration and apoptosis (”
BackgroundOsteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
Morrow, J. J., & Khanna, C. (2015) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2015013713 · Cited by 172
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
Sampson, J. H., Archer, G. E., Mitchell, D. A., Heimberger, A. B., & Bigner, D. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.04.001 · Cited by 172
“[95] Lengauer C, Kinzler KW, Vogelstein B.”
Human papillomaviruses and associated malignancies.
Alani, R. M., & Münger, K. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.330 · Cited by 172
“Aneuploidy accounts for most of the chromosomal defects in tumor cells (Lengauer et al., 1998) and is consistently observed in almost all cancers (Rajagopalan & Lengauer, 2004).”
BackgroundProfound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
Yawalkar, N., Ferenczi, K., Jones, D. A., Yamanaka, K., Suh, K.-Y., Sadat, S., & Kupper, T. S. (2003) · Blood · doi:10.1182/blood-2003-04-1044 · Cited by 172
“9 Discussion Cancers in general, and lymphomas in particular, are considered to be the result of an accumulation of multiple genetic lesions in a single cell (27,28).”
BackgroundCutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen
Surman, D. R., Dudley, M. E., Overwijk, W. W., & Restifo, N. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.562 · Cited by 172
“M ost tumor cells are characterized by genetic instability, which results in deletions and additions to the tumor genome (1) and leads to the generation of new tumor Ags.”
BackgroundChan, T.-F., Carvalho, J., Riles, L., & Zheng, X. F. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240444197 · Cited by 171
On the Mechanism of Gene Amplification Induced under Stress in Escherichia coli
Slack, A., Thornton, P. C., Magner, D. B., Rosenberg, S. M., & Hastings, P. J. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020048 · Cited by 171
“prognosis [1,2], and that arises during tumor progression in”
BackgroundMarkowitz, S. D., Dawson, D. M., Willis, J., & Willson, J. K. V. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00053-3 · Cited by 165
Abdel-Rahman, W. M., Katsura, K., Rens, W., Gorman, P. A., Sheer, D., Bicknell, D., Bodmer, W. F., Arends, M. J., Wyllie, A. H., & Edwards, P. A. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041603298 · Cited by 171
Konishi, H., Mohseni, M., Tamaki, A., Garay, J. P., Croessmann, S., Karnan, S., Ota, A., Wong, H. Y., Konishi, Y., Karakas, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110969108 · Cited by 170
“Because of its high resolution, FISH can delineate genomic instability (measurable rate of genomic changes) in addition to aneuploidy or allelic imbalance (state of genomic changes) (34).”
BackgroundRegulation of kinetochore–microtubule attachments through homeostatic control during mitosis
Godek, K. M., Kabeche, L., & Compton, D. A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3916 · Cited by 170
Reconstructing metastatic seeding patterns of human cancers
Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Bozic, I., Chatterjee, K., Iacobuzio-Donahue, C. A., Vogelstein, B., & Nowak, M. A. (2017) · Nature Communications · doi:10.1038/ncomms14114 · Cited by 170
Elliott, B., & Jasin, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2671-2682.2001 · Cited by 170
“Such a mutator phenotype is now seen as an important contributor to tumorigenesis (23, 27, 34).”
BackgroundThe origins of cancer robustness and evolvability
Tian, T., Olson, S., Whitacre, J. M., & Harding, A. (2011) · Integr. Biol. · doi:10.1039/c0ib00046a · Cited by 169
Blagosklonny, M. V. (2000) · The FASEB Journal · doi:10.1096/fj.99-1078rev · Cited by 170
“Since loss of p53 increase rate of mutations or genomic instability ( 70 ), one can envision that wt p53 may provide advantages in certain conditions.”
BackgroundChromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
Sánchez‐Céspedes, M., Ahrendt, S. A., Piantadosi, S., Rosell, R., Monzó, M., Wu, L., Westra, W. H., Yang, S. C., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 169
Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution
Bakhoum, S. F., & Landau, D. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029611 · Cited by 169
“Numerical CIN is primarily defined by the “rate” at which chromosomes missegregate throughout consecutive cell divisions (Lengauer et al. 1998).”
Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy
Vogel, C., Kienitz, A., Hofmann, I., Müller, R., & Bastians, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207860 · Cited by 168
“During tumorigenesis, polyploidy frequently precedes aneuploidy, which is associated with high malignancy and poor prognosis (Lengauer et al., 1998; Duesberg and Li, 2003; Rajagopalan et al., 2003).”
BackgroundCastellanos, E., Dominguez, P., & Gonzalez, C. (2008) · Current Biology · doi:10.1016/j.cub.2008.07.029 · Cited by 167
“Such collection of experimental conditions brings about a fair recapitulation of the most frequent types of defects in chromosome number and integrity reported in human tumors [1], such as chromosomal rearrangements, aneuploidy, and different levels of polyploidy, including, notably, tetraploidy, which is suspected to…”
BackgroundToward specific functions of poly(ADP-ribose) polymerase-2
Yélamos, J., Schreiber, V., & Dantzer, F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.003 · Cited by 165
Ziegert, C., Wentzensen, N., Vinokurova, S., Kisseljov, F., Einenkel, J., Hoeckel, M., & von Knebel Doeberitz, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206629 · Cited by 167
“…of the full set of cellular DNA-replication factors as well as the viral genes mediating replication of the viral genome result in severe damage of the chromosomal integrity and recombination of diverse DNA sequences (Tlsty, 1997; Lengauer et al., 1998; reviewed by Duensing and Munger, 2002).”
BackgroundChronic immune activation and inflammation in the pathogenesis of aids and cancer
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166
Chronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F. A., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 164
Somatic alterations in the human cancer genome
Weir, B., Zhao, X., & Meyerson, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.004 · Cited by 166
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Conway, J. R., Kofman, E., Mo, S. S., Elmarakeby, H., & Van Allen, E. (2018) · Genome Medicine · doi:10.1186/s13073-018-0605-7 · Cited by 165
Woerner, S. M., Benner, A., Sutter, C., Schiller, M., Yuan, Y. P., Keller, G., Bork, P., Doeberitz, M. V. K., & Gebert, J. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206421 · Cited by 165
“The type and spectrum of mutated genes markedly differ among CIN and MSI-H tumors (Ionov et al., 1993; Konishi et al., 1996; Lengauer et al., 1998), suggesting distinct but not mutually exclusive pathways of carcinogenesis (Perucho et al., 1994).”
BackgroundZhu, Y., Qi, C., Jain, S., Le Beau, M. M., Espinosa, R., Atkins, G. B., Lazar, M. A., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10848 · Cited by 165
Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
Yan, B., Wang, H., Rabbani, Z. N., Zhao, Y., Li, W., Yuan, Y., Li, F., Dewhirst, M. W., & Li, C.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2540 · Cited by 165
“Increased instability can result in accumulation of mutations in critical genes, such as oncogenes and tumor suppressor genes (17).”
BackgroundAlberts, D. S., Colvin, O. M., Conney, A. H., Ernster, V. L., Garber, J., Greenwald, P., Gudas, L. J., Hong, K. H. W. K., Kelloff, G. J., Kramer, R. A., et al. (1999) · PubMed · Cited by 185
Epigenetic drivers and genetic passengers on the road to cancer
Sawan, C., Vaissière, T., Murr, R., & Herceg, Z. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.03.002 · Cited by 166
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
Castello, G., Scala, S., Palmieri, G., Curley, S. A., & Izzo, F. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.10.007 · Cited by 164
High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells
Daniel, J., Coulter, J., Woo, J.-H., Wilsbach, K., & Gabrielson, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007645108 · Cited by 157
“Paradoxically, although chromosomal instability and aneuploidy are hallmarks of cancer and generally regarded as contributors to carcinogenesis (2, 4), normal eukaryotic cells are highly intolerant of aneuploidy (3, 5, 6).”
BackgroundMeasuring cancer evolution from the genome
Graham, T. A., & Sottoriva, A. (2017) · The Journal of Pathology · doi:10.1002/path.4821 · Cited by 163
“Larger-scale chromosomal or part-chromosome losses or amplifications [somatic copy number alterations (SCNAs)] and other structural rearrangements also occur at an appreciable frequency in many cancers [5,6].”
BackgroundNormal stem cells and cancer stem cells: similar and different
Shackleton, M. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.002 · Cited by 164
DNA replication fidelity and cancer
Preston, B. D., Albertson, T. M., & Herr, A. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.009 · Cited by 160
“[14].”
BackgroundPoly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis
Tong, W.-M., Cortes, U., & Wang, Z.-Q. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00035-x · Cited by 163
Non-homologous DNA end joining.
Pastwa, E., & Błasiak, J. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3622 · Cited by 163
“Cancer is very often associated with the accumulation of genomic aberrations including large deletions, inversion or translocations, which may be consequences of DSBs (Lengauer et al., 1998).”
BackgroundCentrosome replication, genomic instability and cancer
Krämer, A., Neben, K., & Ho, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402454 · Cited by 163
Stochastic cancer progression driven by non‐clonal chromosome aberrations
Heng, H. H. Q., Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., Reddy, P., Wu, G. S., Wang, Y. A., Tainsky, M. A., & Ye, C. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20685 · Cited by 162
Molecular pathogenesis of colorectal cancer: Implications for molecular diagnosis
Arnold, C. N., Goel, A., Blum, H. E., & Richard Boland, C. (2005) · Cancer · doi:10.1002/cncr.21462 · Cited by 162
“Microsatellite instability Tumors that develop through inactivation of tumorsuppressor genes and multiple allelic losses are referred to as having “chromosomal instability” (CIN) and evolve through the “suppressor” pathway.(46) Although this model was the initial model for multistep tumor progression, we now know that…”
BackgroundCimini, D., Fioravanti, D., Salmon, E. D., & Degrassi, F. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.507 · Cited by 161
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161
Shen, C., Yu, J.-C., Lo, Y.-L., Kuo, C. H., Yue, C. T., Jou, Y., Huang, C., Lung, J. C., & Wu, C.-H. (2000) · PubMed · Cited by 169
Rao, C. V., Yang, Y.-M., Swamy, M. V., Liu, T., Fang, Y., Mahmood, R., Jhanwar-Uniyal, M., & Dai, W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407822102 · Cited by 160
Rücker, F. G., Bullinger, L., Schwaenen, C., Lipka, D. B., Wessendorf, S., Fröhling, S., Bentz, M., Miller, S., Scholl, C., Schlenk, R. F., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5450 · Cited by 160
Drugging the Cancers Addicted to DNA Repair
Nickoloff, J. A., Jones, D., Lee, S.-H., Williamson, E. A., & Hromas, R. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx059 · Cited by 159
“cells with inherited or acquired DNA repair defects (7,8,20).”
BackgroundWhole chromosome instability and cancer: a complex relationship
Ricke, R. M., van Ree, J. H., & van Deursen, J. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.07.002 · Cited by 159
Oxidative stress at low levels can induce clustered DNA lesions leading to NHEJ mediated mutations
Sharma, V., Collins, L. B., Chen, T.-H., Herr, N., Takeda, S., Sun, W., Swenberg, J. A., & Nakamura, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8298 · Cited by 159
“However, most human tumors are characterized by large genome rearrangements [8].”
BackgroundSubgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
Auclin, E., Zaanan, A., Vernerey, D., Douard, R., Gallois, C., Laurent-Puig, P., Bonnetain, F., & Taieb, J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx030 · Cited by 159
Extensive genetic variation in somatic human tissues
O’Huallachain, M., Karczewski, K. J., Weissman, S. M., Urban, A. E., & Snyder, M. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213736109 · Cited by 158
Telomeres and telomerase: A dual role in hepatocarcinogenesis
Satyanarayana, A., Manns, M. P., & Rudolph, L. K. (2004) · Hepatology · doi:10.1002/hep.20308 · Cited by 158
Mann, M. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi075 · Cited by 159
Checkpoint activation regulates mutagenic translesion synthesis
Kai, M., & Wang, T. S.-F. (2003) · Genes & Development · doi:10.1101/gad.1043203 · Cited by 158
Bolaños-García, V. M. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.021 · Cited by 157
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues
Lambert, G., Estévez-Salmerón, L., Oh, S., Liao, D., Emerson, B. M., Tlsty, T. D., & Austin, R. H. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3039 · Cited by 170
“Conversely, the traditional interpretation of evolvability and why it appears so often in cancer tissues — where it is usually referred to as genetic instability 29 — often relies on assuming that random mutations cause the failure of DNA protection processes.”
BackgroundTsantoulis, P. K., Kotsinas, A., Sfikakis, P. P., Evangelou, K., Sideridou, M., Levy, B., Mo, L., Kittas, C. N., Wu, X., Papavassiliou, A. G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210989 · Cited by 176
“In a smaller subset of cancer types, particularly hereditary nonpolyposis colon cancer, genomic instability is observed at the nucleotide level with nucleotide insertions, deletions and substitutions due to mismatch repair gene defects (Lengauer et al., 1998).”
BackgroundDysregulation of apoptosis genes in hematopoietic malignancies
Kitada, S., Pedersen, I. M., Schimmer, A. D., & Reed, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205327 · Cited by 179
“Hereditary mutations in the ATM gene were ®rst associated with ataxia telangiectasia, a syndrome characterized by defective DNA repair and a high incidence of T-cell neoplasms (reviewed in Lengauer et al., 1998).”
BackgroundChromosome rearrangements resulting from telomere dysfunction and their role in cancer
Murnane, J. P., & Sabatier, L. (2004) · BioEssays · doi:10.1002/bies.20125 · Cited by 179
γH2AX as a molecular marker of aging and disease
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Epigenetics · doi:10.4161/epi.5.2.11080 · Cited by 153
Dysfunctional homologous recombination mediates genomic instability and progression in myeloma
Shammas, M. A., Shmookler Reis, R. J., Koley, H., Batchu, R. B., Li, C., & Munshi, N. C. (2009) · Blood · doi:10.1182/blood-2007-05-089193 · Cited by 155
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer
Shi, C., Yang, Y., Xia, Y., Okugawa, Y., Yang, J., Liang, Y., Chen, H., Zhang, P., Wang, F., Han, H., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308455 · Cited by 154
Molecular Pathogenesis of Primary Hyperparathyroidism
Lauter, K., & Arnold, A. (2012) · Handbook of Parathyroid Diseases · doi:10.1007/978-1-4614-2164-1_16 · Cited by 158
“irradiation or chemical carcinogens, or from intrinsic errors in DNA/chromosomal replication [ 3 ] .”
BackgroundDrouet, J., Delteil, C., Lefrançois, J., Concannon, P., Salles, B., & Calsou, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410746200 · Cited by 154
Genomic instability in breast cancer: Pathogenesis and clinical implications
Kwei, K. A., Kung, Y., Salari, K., Holcomb, I. N., & Pollack, J. R. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.001 · Cited by 154
“…instability (also called “mutator phenotype”) is believed to be necessary for cells to accumulate the multiple mutations required for cancer to develop (Loeb, 2001), and is thought to result from dysfunction of genome “caretaker” genes (Kinzler and Vogelstein, 1997) early on during carcinogenesis.”
BackgroundPathology and molecular biology of gastric cancer
Vauhkonen, M., Vauhkonen, H., & Sipponen, P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.03.016 · Cited by 154
Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint
Sironi, L., Melixetian, M. B., Faretta, M., Prosperini, E., Helin, K., & Musacchio, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6371 · Cited by 154
Arlotta, P., Tai, A., Manfioletti, G., Clifford, C. B., Jay, G., & Ono, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000564200 · Cited by 156
MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaks
Shao, G., Patterson-Fortin, J., Messick, T. E., Feng, D., Shanbhag, N., Wang, Y., & Greenberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1739609 · Cited by 154
“However, germline mutations in DNA repair and checkpoint control genes abrogate this response, which leads to genomic instability and a predisposition to neoplasia (Lengauer et al. 1998; DePinho 2000; Rouse and Jackson 2002; Venkitaraman 2002).”
BackgroundReshkin, S. J., Bellizzi, A., Albarani, V., Guerra, L., Tommasino, M., Paradiso, A., & Casavola, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5361 · Cited by 153
Thompson, S. L., & Compton, D. A. (2010) · Chromosome Research · doi:10.1007/s10577-010-9179-y · Cited by 183
“It is thought that mutations in proteins that permit cell cycle progression in the presence of double stranded breaks (such as mutations in p53, BRCA1, BRCA2, ATM, and ATR) may facilitate CSI (Lengauer et al. 1998).”
Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer
Frigola, J., Solé, X., Paz, M. F., Moreno, V., Esteller, M., Capellà, G., & Peinado, M. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi028 · Cited by 152
Transcriptional regulation of lymphocyte lineage commitment
Rothenberg, E. V., Telfer, J. C., & Anderson, M. K. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199909)21:9<726::aid-bies4>3.0.co;2-s · Cited by 46
Yao, R., Zhang, Z., An, X., Bucci, B., Perlstein, D. L., Stubbe, J., & Huang, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131932100 · Cited by 151
Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses
Siegrist, K. J., Reynolds, S. H., Kashon, M. L., Lowry, D. T., Dong, C., Hubbs, A. F., Young, S.-H., Salisbury, J. L., Porter, D. W., Benkovic, S. A., et al. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-6 · Cited by 151
“Aberrant cell signaling is a concern because it is important in the progression of carcinogenesis [81-83].”
BackgroundDebate Surges Over the Origins of Genomic Defects in Cancer
Marx, J. L. (2002) · Science · doi:10.1126/science.297.5581.544 · Cited by 151
DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
Wilhelm, T., Said, M., & Naim, V. (2020) · Genes · doi:10.3390/genes11060642 · Cited by 173
“, an ongoing CIN, a common feature of cancer [262], is also associated with developmental diseases and neurodegenerative conditions.”
BackgroundRigaud, G., Missiaglia, E., Moore, P. S., Zamboni, G., Falconi, M., Talamini, G., Pesci, A., Baron, A., Lissandrini, D., Rindi, G., et al. (2001) · PubMed · Cited by 150
Non‐B DNA conformations as determinants of mutagenesis and human disease
Bacolla, A., & Wells, R. D. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20507 · Cited by 152
“Genetic instabilities are involved in the etiology of cancers [4] as well as hereditary neurological diseases [5].”
BackgroundMouradov, D., Domingo, E., Gibbs, P., Jorissen, R. N., Li, S., Soo, P. Y., Lipton, L., Desai, J., Danielsen, H. E., Oukrif, D., et al. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.292 · Cited by 148
Li, X., Galipeau, P. C., Paulson, T. G., Sanchez, C. A., Arnaudo, J., Liu, K., Sather, C. L., Kostadinov, R. L., Odze, R. D., Kuhner, M. K., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0289 · Cited by 149
Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum
Jass, J. R., Young, J. P., & Leggett, B. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.01028.x · Cited by 148
Maitra, A., Wistuba, I. I., Washington, C., Virmani, A. K., Ashfaq, R., Milchgrub, S., Gazdar, A. F., & Minna, J. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61679-3 · Cited by 148
“Although it is tempting to speculate that these discrete areas may harbor one or more TSG(s) critical in carcinogenesis, an alternative argument that needs to be addressed is whether these discontinuous breaks merely represent mutational predisposition.(64) It has been shown in cohorts of hereditary breast cancer pati…”
BackgroundCuny, M., Kramar, A., Courjal, F., Johannsdottir, V., Iacopetta, B. J., Fontaine, H., Grenier, J., Culine, S., & Theillet, C. G. (2000) · PubMed · Cited by 148
Adaptive mechanisms in pathogens: universal aneuploidy in Leishmania
Mannaert, A., Downing, T., Imamura, H., & Dujardin, J. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.06.003 · Cited by 166
Boleij, A., & Tjalsma, H. (2012) · Biological Reviews · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 146
Oncogenic MicroRNAs: Key Players in Malignant Transformation
Frixa, T., Donzelli, S., & Blandino, G. (2015) · Cancers · doi:10.3390/cancers7040904 · Cited by 147
“Alterations in DNA, caused by genetic mutations determining structural and expression modification, at coding and non-coding regions, are responsible for cancer occurrence, gradual increase in tumor size, disorganization and malignancy [1].”
BackgroundMan, T.-K., Lu, X.-Y., Jaeweon, K., Perlaky, L., Harris, C. P., Shah, S., Ladanyi, M., Gorlick, R., Lau, C. C., & Rao, P. H. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-45 · Cited by 148
“Gene amplification is an important genetic mechanism in human cancers, as it clearly associated with tumor progression and has a prognostic significance and has even provided a target for therapeutics [17,18].”
BackgroundZhang, D., Hirota, T., Marumoto, T., Shimizu, M., Kunitoku, N., Sasayama, T., Arima, Y., Feng, L., Suzuki, M., Takeya, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208153 · Cited by 147
“Chromosomal instability and aneuploidy are remarkable hallmarks of human cancers (Lengauer et al., 1998; Cahill et al., 1999).”
Background
Metadata
- Authors
- Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6712
- Pages
- 643-649
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1544851750
- Cited by
- 4,168
- References
- 98
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 56 · 2023: 74 · 2022: 83 · 2021: 91 · 2020: 92 · 2019: 90 · 2018: 99 · 2017: 106 · 2016: 113 · 2015: 136 · 2014: 145 · 2013: 156 · 2012: 183
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- genomic instability, carcinogenesis, chromosomal instability, microsatellite instability, base substitutions, chromosomal deletion, chromosomal gains, cancer genetics
- MeSH terms
- Chromosome Aberrations, Gene Amplification, Humans, Neoplasms, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.